For US Healthcare Professionals Only
Through multiple clinical trials in a variety of disease areas, UCB has generated a wealth of data in patients living with immunologic conditions and rare diseases. UCB is committed to sharing information about our clinical trials and making the results of these studies publically available. By making patient-level data from UCB clinical studies available to our scientific collaborators, we help support analyses that will inform and guide patient care.
Qualified researchers may request access to anonymized patient-level data and supporting documents that have been redacted to protect personally identifiable information from UCB-sponsored clinical studies via Vivli.org. Vivli is a multi-sponsor request management system that facilitates the responsible sharing of patient-level data from a range of clinical study Sponsors/Funders through a research-friendly platform.
In addition to the studies already listed on Vivli.org, UCB will consider ad hoc requests for additional Phase II-IV UCB-sponsored interventional clinical studies that started on or after January 1, 2007 to be added to Vivli.
Should you have any questions, you can contact us at datasharing.coordinator@ucb.com